首页|基于肠黏膜屏障功能及氧化应激反应分析硫唑嘌呤联合柳氮磺吡啶治疗溃疡性结肠炎的效果

基于肠黏膜屏障功能及氧化应激反应分析硫唑嘌呤联合柳氮磺吡啶治疗溃疡性结肠炎的效果

扫码查看
目的 基于肠黏膜屏障功能及氧化应激反应分析硫唑嘌呤联合柳氮磺吡啶治疗溃疡性结肠炎的效果。方法 本研究选取2019年1月至2022年10月许昌医院182例溃疡性结肠炎患者,按照随机数字表法分两组,各91例。常规组给予柳氮磺吡啶,在此基础上试验组给予硫唑嘌呤。比较两组疗效,症状改善情况,肠黏膜屏障功能[D-乳酸(D-LA)、二胺氧化酶(DAO)、内毒素(BT)],氧化应激反应[丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)],不良反应。结果 连续治疗3个月后,试验组总有效率较常规组高(P<0。05);试验组腹泻、血便消失时间较常规组短(P<0。05);试验组Sutherland评分低于常规组(P<0。05);试验组BT、DAO、D-LA、MDA低于常规组,GSH-Px、SOD高于常规组(P<0。05);两组不良反应发生率差异无统计学意义(P>0。05)。结论 硫唑嘌呤联合柳氮磺吡啶治疗溃疡性结肠炎安全有效,并能保护肠黏膜屏障,减轻氧化应激。
Based on the Intestinal Mucosal Barrier Function and Oxidative Stress Response,Analysis the Effect of the Combination of Azathioprine and Sulfasalazine in the Treatment of Ulcerative Colitis
Objective To analyze the effect of the combination of azathioprine and sulfasalazine in the treatment of ulcerative colitis (UC) based on intestinal mucosal barrier function and oxidative stress response. Methods 182 patients with UC in Xuchang Hospital from January 2019 to October 2022 were selected and randomly divided into two groups,each with 91 cases,according to a random number table method. The conventional group was given sulfasalazine,and on this basis,the experimental group was given azathioprine. The efficacy,symptom improvement,intestinal mucosal barrier function[D-lactate (D-LA),diamine oxidase (DAO),endotoxin (BT)],oxidative stress response[malondialdehyde (MDA),glutathione peroxidase (GSH-Px),superoxide dismutase (SOD)],and adverse reactions were compared between the two groups. Results After 3 months of continuous treatment,the total effective rate of the experimental group was higher than that of the conventional group (P<0.05);the disappearance time of diarrhea and bloody stool in the experimental group was shorter than that in the conventional group (P<0.05);the Sutherland score in the experimental group was lower than that in the conventional group (P<0.05);the levels of BT,DAO,D-LA,and MDA in the experimental group were lower than those in the conventional group,while the levels of GSH-Px and SOD were higher than those in the conventional group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion The combination of azathioprine and sulfasalazine is safe and effective in the treatment of UC and protects the intestinal mucosal barrier and reduces oxidative stress.

Ulcerative colitisAzathioprineIntestinal mucosal barrier functionSulfasalazineOxidative stress

李凯、宋秋环、王伟伟

展开 >

许昌医院,河南许昌 461000

溃疡性结肠炎 硫唑嘌呤 肠黏膜屏障功能 柳氮磺吡啶 氧化应激

2024

药品评价
江西省药学会

药品评价

影响因子:0.672
ISSN:1672-2809
年,卷(期):2024.21(8)